Published • loading... • Updated
Vyalev eases motor, nonmotor symptoms in advanced Parkinson's
Summary by Parkinson's News Today
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Vyalev eases motor, nonmotor symptoms in advanced Parkinson's
Vyalev, Abbvie‘s continuous under-the-skin infusion formulation of levodopa/carbidopa, reduces off time and eases motor and some nonmotor symptoms in adults with advanced Parkinson’s disease. That’s according to six-month data from an ongoing real-world study, ROSSINI (NCT06107426), which also showed the therapy improves patients’ quality of life. The trial is evaluating Vyalev in routine clinical practice across 10 countries in 427 adults with …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
